Product Images Atorvastatin Calcium

This is a description of a medication named Atorvastatin Calcium, mainly indicating the drug's name, dosage, manufacturer details, lot numbers, and expiration dates. The text also includes a caution to prevent children from coming in contact with the medication and recommends storing it at a controlled temperature between 68-77 degrees Fahrenheit. Additionally, the product label advises that users should consult with their healthcare provider in case of side effects and informs them that they can report any side effects to FDA.*

This document appears to be a graph that shows the cumulative incidence of something over a period of 35 years. The graph has two lines: One represents Atorvastatin and the other represents Placebo. At the 35-year mark, the cumulative incidence for Atorvastatin is around 10%, while the cumulative incidence for Placebo is around 30%. Additionally, there is a statistic shown in the graph: HR=064 (050089) p=00005.*

This is a plot of the cumulative hazard percentage for a clinical trial comparing a placebo group to a group taking Atorvastatin. The hazard ratio (HR) is 0.63, indicating a lower risk of primary endpoint events (not specified) in the Atorvastatin group. The x-axis shows time in years, with data collected over four years of follow-up.*

This text provides information on the subjects who experienced a major cardiovascular endpoint after taking Atorvastatin 10mg or 80mg. The data shows that 0.2% of the subjects experienced the event at 10mg, while the percentage is not provided for 80mg. The Hazard Ratio (HR) for Atorvastatin 80mg is given as 0.78 with a confidence interval and P-value. The graph shows the time (in years) to the first major cardiovascular endpoint for both dosage groups.*